Clinical Senior Lecturer and Honorary Consultant in Hepatobiliary and Pancreatic Surgery. Has a clinical interest in HPB Surgery with a specific focus on minimally invasive techniques, the use of radiofrequency energy as a resection tool, cholangiocarcinomas and neuroendocrine tumours.
- BSc in Biochemistry, University of Southampton, 1985
- MB ChB, University of Birmingham, 1989
- FRCS (Eng), 1993
- FRCS (Gen Surg), 2002
- MD, University of London, 2006
- Molecular pathogenesis of cholangiocarcinomas to identify novel therapeutic targets.
- Early detection of cholangiocarcinomas using novel biomarkers
- Synthesis of novel molecular conjugates comprising chemotherapeutic agents and transporter molecules for targeted delivery to cholangiocarcinomas.
- Stellate cancer-associated fibroblasts contribution to chemoresistance of pancreatic ductal adenocarcinoma.
Membership of Professional Bodies
- Association of Surgeons of Great Britain and Ireland
- Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland
- Fellow of the Royal College of Surgeons of England
- International Hepatopancreatobiliary Association
- Royal Society of Medicine
- British Medical Association
- Module leader BSc in Surgery and Anaesthesia (Module 1: Regeneration, repair and cancer control).
- BSc in Gastroenterology and Hepatology
- MSc in Surgical Science
- MSc in Surgical Technology
- Whipps Cross Higher Surgery Course
- Supervising 2 PhD, 2 MSc and 1 MRes Projects
- Sub-editor of the Journal of HPB Surgery
et al., 2007, Pancreatic cancer, Medicine
et al., 2017, A systematic review on radiofrequency assisted laparoscopic liver resection: Challenges and window to excel, Surgical Oncology-oxford, Vol:26, ISSN:0960-7404, Pages:296-304
et al., 2017, Non-alcoholic fatty liver disease: A sign of systemic disease, Metabolism-clinical and Experimental, Vol:72, ISSN:0026-0495, Pages:94-108
et al., Surgical Management of Cholangiocarcinoma, 9th World Congress of the International Hepato-Pancreato-Biliary Association, Pages:1-468
et al., Array comparative genomic hybridization identifies novel potential therapeutic targets for cholangiocarcinoma., 9th World Congress of the International Hepato-Pancreato-Biliary Association, Pages:1-468